Estrategias de control y prevención de sangrado en pacientes sometidos a cirugía plástica reconstructiva y estética.
Palabras clave:
Cirugía plástica, ácido tranexámico, sangrado perioperatorio, anticoagulación, antiagregación.Resumen
El control del sangrado perioperatorio es fundamental en cirugía plástica reconstructiva y estética, especialmente en pacientes que reciben antifibrinolíticos, anticoagulantes o antiagregantes plaquetarios. Esta revisión sintetiza la evidencia sobre el uso del ácido tranexámico, demostrando beneficios en la reducción del sangrado y la equimosis en diversos procedimientos, aunque muestra resultados variables en cirugía facial y palpebral. Asimismo, se analiza el papel de las heparinas en la supervivencia de los colgajos libres, las limitaciones del uso de la aspirina por su asociación con un mayor número de complicaciones y, finalmente, se destaca la necesidad de enfoques individualizados ante la falta de guías específicas en cirugía plástica.
Descargas
Referencias
1. Tamayo A, Cuastumal D. Versatilidad terapéutica del ácido tranexámico aplicado a la Cirugía Plástica. Revisión bibliográfica. Cir. plást. iberolatinoam. 2022; 48(4):383-94. DOI:10.4321/S0376-78922022000400005.
2. Carrascal H. Uso de ácido tranexámico como método de ahorro sanguíneo en pacientes sometidos a liposucción y otras cirugías estéticas en un centro especializado en la ciudad de Bogotá [tesis]. Cartagena: Universidad del Sinú, Escuela de Medicina; 2020.
3. Behroozian T, Fang E, Douketis J, Retrouvey H, Thoma A. Perioperative management of antithrombotic therapy in patients undergoing plastic and reconstructive surgery: a practical tool based on current guidelines. Plast Surg. 2025; 33(4):677-83. DOI:10.1177/22925503241256654.
4. Rendenbach C, Hölterhoff N, Hischke S, Kreutzer K, Smeets R, Assaf A.T, et al. Free flap surgery in Europe: an interdisciplinary survey. Int J Oral Maxillofac Surg. 2018; 47(5):676-82. DOI:10.1016/j.ijom.2017.11.013
5. Fukui A, Maeda M, Sempuku T, Tamai S, Mizumoto S, Inada Y. Continuous local intra-arterial infusion of anticoagulants for digit replantation and treatment of damaged arteries. J Reconstr Microsurg. 1989; 5(2):127-36. DOI:10.1055/s-2007-1006860
6. Saito A, Sawaizumi M, Imai T, Matsumoto S. Continuous local intra-arterial infusion of anticoagulants for microvascular free tissue transfer in primary reconstruction of the lower limb following resection of sarcoma. Microsurgery. 2010; 30(5):376-9. DOI:10.1002/micr.20742
7. Filipan D, Dediol E, Blivajs I, Milic M. The Effects of Dextran on Postoperative Thrombosis and Hemodilution in Microvascular Head and Neck Reconstruction. Ann Plast Surg. 2020; 85(1):38-42. DOI: 10.1097/SAP.0000000000002148.
8. Numajiri T, Sowa Y, Nishino K, Arai A, Tsujikawa T, Ikebuchi K, et al. Uso de heparina no fraccionada sistémica de baja dosis en la reconstrucción microvascular de cabeza y cuello: influencia en los resultados del colgajo libre. J Plast Surg Hand Surg. 2016; 50(3):135-41. DOI:10.3109/2000656X.2015.1125359.
9. Okochi M, Komuro Y, Ueda K. Selective and Continuous Transarterial Heparin Infusion: Postmicrosurgical Therapy of Lower Leg Reconstruction for Cases with Recipient Artery Damage. World J Plast Surg. 2019; 8(3):298-304. DOI:10.29252/wjps.8.3.298.
10. Riva FMG, Chen YC, Tan NC, Lin PY, Tsai YT, Chang HW, et al. The outcome of prostaglandin-E1 and dextran-40 compared to no antithrombotic therapy in head and neck free tissue transfer: analysis of 1,351 cases in a single center. Microsurgery. 2012; 32:339-43. DOI:10.1002/micr.21958.
11. Scarafoni E. A systematic review of tranexamic acid in plastic surgery: what’s new? Plast Reconstr Surg Glob Open. 2021; 9:e3172. DOI:10.1097/GOX.0000000000003172.
12. McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs. 2012; 72(5):585-617. DOI:10.2165/11209070-000000000-00000.
13. Franchini M, Mengoli C, Cruciani M, Bergamini V, Presti F, Marano G, et al. Safety and efficacy of tranexamic acid for prevention of obstetric haemorrhage: an updated systematic review and meta-analysis. Blood Transfus. 2018; 16(4):329-37. DOI:10.2450/2018.0026-18.
14. Beikaei M, Ghazipour A, Derakhshande V, Saki N, Nikakhlagh S. Evaluating the Effect of Intravenous Tranexamic Acid on Intraoperative Bleeding During Elective Rhinoplasty Surgery. Biomed Pharmacol J. 2015; 8:753-9. DOI:10.13005/bpj/779.
15. Ghavimi M, Taheri Talesh K, Ghoreishizadeh A, Chavoshzadeh M, Zarandi A. Efficacy of tranexamic acid on side effects of rhinoplasty: A randomized double-blind study. J Craniomaxillofac Surg. 2017;45(6):897-902. DOI:10.1016/j.jcms.2017.03.001.
16. Couto RA, Charafeddine A, Sinclair NR, Nayak LM, Zins JE. Local Infiltration of Tranexamic Acid With Local Anesthetic Reduces Intraoperative Facelift Bleeding: A Preliminary Report. Aesthet Surg J. 2020;40(6):587-93. DOI:10.1093/asj/sjz232.
17. Ausen K, Hagen AI, Østbyhaug HS, Olafsson S, Kvalsund BJ, Spigset O, et al. Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial. BJS Open. 2020; 4(2):216-24. DOI:10.1002/bjs5.50248.
18. Hernández J. Evaluación de equimosis postquirúrgica en cirugía palpebral en un estudio de casos y controles tratados con solución de ácido tranexámico intraoperatorio [Trabajo Fin de Grado]. Murcia: Universidad Católica de Murcia; 2022.
19. Qin H, Deng C. Research progress on perioperative anticoagulants in perioperative period of free flap transplantation. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025; 39(11):1474-84. DOI: 10.7507/1002-1892.202507042.
20. Zhou W, Zhang WB, Yu Y, Wang Y, Mao C, Guo C.-B, et al. Risk factors for free flap failure: a retrospective analysis of 881 free flaps for head and neck defect reconstruction. Int J Oral Maxillofac Surg. 2017; 46(8):941-945. DOI:10.1016/j.ijom.2017.03.023
21. Swartz JE, Aarts MCJ, Swart KMA, Disa JJ, Gerressen M, Kuo YR, et al. The value of postoperative anticoagulants to improve flap survival in the free radial forearm flap: a systematic review and retrospective multicentre analysis. Clin Otolaryngol. 2015; 40(6):600-9. DOI:10.1111/coa.12425.
22. Burkhard JP, Pfister J, Giger R, Hurber M, Lädrach C, Waser M, et al. Perioperative predictors of early surgical revision and flap-related complications after microvascular free tissue transfer in head and neck reconstructions: a retrospective observational series. Clin Oral Investig. 2021; 25(9):5541-5550. DOI:10.1007/s00784-021-03864-1
23. Karimi E, Ardestani SH, Jafari M, Hagh AB. Testing a New Anticoagulation Method for Free Flap Reconstruction of Head and Neck Cancers. Clin Exp Otorhinolaryngol. 2016; 9(4):370-373. DOI:10.21053/ceo.2015.01781
24. Dawoud BES, Kent S, Tabbenor O, Markose G, Java K, Kyzas P. Does anticoagulation improve outcomes of microvascular free flap reconstruction following head and neck surgery: a systematic review and meta-analysis. Br J Oral Maxillofac Surg. 2022; 60(10):1292-1302. DOI:10.1016/j.bjoms.2022.07.016
25. Sigaux N, Philouze P, Boucher F, Jacquemart M, Frobert P, Breton P. Efficacy of the postoperative management after microsurgical free tissue transfer. J Stomatol Oral Maxillofac Surg. 2017; 118(3):173-7. DOI:10.1016/j.jormas.2017.03.007.
26. Cevik J, Middleton R, Ramakrishnan A, Cabalag M. Racionalización de la anticoagulación profiláctica posoperatoria en pacientes con cáncer de cabeza y cuello reconstructivo: una revisión. ANZ J Surg. 2021; 91:2610-6. DOI:10.1111/ans.16742.
27. Couteau C, Rem K, Guillier D, Moris V, Revol M, Cristofari S, et al. Improving free-flap survival using intra-operative heparin: ritualistic practice or evidence-based medicine? A systematic review. Ann Chir Plast Esthet. 2018; 63(3):e1-5. DOI:10.1016/j.anplas.2017.06.010.
28. Lin PT, Wang SH, Chi CC. Low molecular weight heparin for prevention of microvascular occlusion in digital replantation. Cochrane Database Syst Rev. 2020; 4:CD009894. DOI:10.1002/14651858.CD009894.pub3.
29. Liu J, Shi Q, Yang S, Liu B, Guo B, Xu J. Does postoperative anticoagulation therapy lead to a higher success rate of free flap transfer in the head and neck? A systematic review and meta-analysis. J Reconstr Microsurg. 2018; 34(2):87-94. DOI:10.1055/s-0037-1606346.
30. Pršić A, Kiwanuka E, Caterson SA, Caterson EJ. Anticoagulants and Statins As Pharmacological Agents in Free Flap Surgery: Current Rationale. Eplasty. 2015; 15:e51.
31. Trull B, Zhang Z, Boyd K, Allen M, Zhang J. Canadian Postoperative Dependency Protocols Following Lower Limb Microvascular Reconstruction: A National Survey and Literature Review. Cir Plast. 2020; 29(2):122-7. DOI:10.1177/2292550320954093.
32. Pan XL, Chen GX, Shao HW, Han CM, Zhang LP, Zhi LZ. Effect of heparin on prevention of flap loss in microsurgical free flap transfer: a meta-analysis. PLoS One. 2014; 9(4):e95111. DOI: 10.1371/journal.pone.0095111.
33. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3):338-400. DOI:10.1378/chest.126.3_suppl.338S.
34. Nast A, Häfner HM, Kolk A, Koscielny J, Kunte C, Löser C, et al. S3 guideline: Management of anticoagulants and antiplatelet agents in cutaneous surgery. J Dtsch Dermatol Ges. 2021; 19(10):1531–52. DOI:10.1111/ddg.14522.
35. Robson A, Sturman J, Williamson P, Conboy P, Penney S, Wood H. Pre-treatment clinical assessment in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016; 130(2):13-22. DOI: 10.1017/S0022215116000372.
36. Douketis JD, Spyropoulos AC, Murad MH, Arcelus JI, Dager WE, Dunn AS, et al. Perioperative management of antithrombotic therapy: an American College of Chest Physicians clinical practice guideline. Chest. 2022; 162(5):e207-43. DOI:10.1016/j.chest.2022.07.025.
37. Chan NC, Weitz JI. Antithrombotic Agents. Circ Res. 2019; 124(3):426-36. DOI:10.1161/CIRCRESAHA.118.313155.
38. Samama CM, Djoudi R, Lecompte T, Nathan-Denizot N, Schved JF; Agence Française de Sécurité Sanitaire des Produits de Santé expert group. Perioperative platelet transfusion: recommendations of the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS) 2003. Can J Anaesth. 2005;52(1):30-7. DOI:10.1007/BF03018577
39. Patel PA, Fleisher LA. Aspirin, clopidogrel, and the surgeon. Adv Surg. 2014; 48:211-22. DOI:10.1016/j.yasu.2014.05.005.
40. Michelson AD. Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov. 2010; 9(2):154-69. DOI:10.1038/nrd2957.
41. Bleymehl M, Moratin J, Smielowski M, Schnug G, Rückschloß T, Busch C, et al. Postoperative anticoagulation in patients with microvascular reconstruction - a systematic review. Oral Maxillofac Surg. 2025; 29(1):55. DOI: 10.1007/s10006-025-01351-5.
42. Biermann N, Chak JC, Wiesmeier A, Klein SM, Spoerl S, Kruppa P, et al. Evidence-Based Approaches to Anticoagulation in Reconstructive Microsurgery-A Systematic Literature Review. Life. 2024; 14(1):82. DOI:10.3390/life14010082.
43. Karamanos E, Hazboun R, Saad N, Bialowas C, Wang H, Cromack D. Full versus Baby Dose Aspirin for Antithrombotic Prophylaxis in Free Tissue Transfer: Does Size Matter? Plast Reconstr Surg Glob Open. 2022; 10(12):e4719. DOI: 10.1097/GOX.0000000000004719.
44. Mishu MD, Zolper EG, Dekker PK, Fleury CM, Bekeny JC, Fan KL, et al. Should Antiplatelet Therapy Be Withheld Perioperatively? The First Study Examining Outcomes in Patients Receiving Dual Antiplatelet Therapy in the Lower Extremity Free Flap Population. Plast Reconstr Surg. 2022;149(1):95e-103e. DOI: 10.1097/PRS.0000000000008666.
45. Swiekatowski KR, Woods DE, Wang EB, Acevedo E Jr, Hopkins DC, Bhadkamkar MA, et al. Optimizing Postoperative Anticoagulation Regimen to Improve Lower Extremity Free Flap Outcomes. J Reconstr Microsurg. 2025. DOI:10.1055/a-2555-2252.
46. Hwang MS, Britt CJ, Vila PM, Dang RP, Fleming SI, Patel AM, et al. Factors associated with skin graft take in fibula and radial forearm free flap donor sites. Am J Otolaryngol. 2020;4 1(4):102536. DOI:10.1016/j.amjoto.2020.102536.
47. O’Riordan JM, Margey RJ, Blake G, O’Connell PR. Antiplatelet agents in the perioperative period. Arch Surg. 2009;144(1):69-76. DOI: 10.1001/archsurg.144.1.69.
48. Lindvall G, Sartipy U, van der Linden J. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting. Ann Thorac Surg. 2005; 80(3):922-7. DOI:10.1016/j.athoracsur.2005.03.079
49. Altman R, Scazziota A, DE Lourdes Herrera M, Gonzalez C. Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation. J Thromb Haemost. 2006; 4(9):2022-7. DOI:10.1111/j.1538-7836.2006.02088.x
50. Collet JP, Himbet F, Steg PG. Myocardial infarction after aspirin cessation in stable coronary artery disease patients. Int J Cardiol. 2000;76(2-3):257-8. DOI:10.1016/s0167-5273(00)00399-5
51. Neilipovitz DT, Bryson GL, Nichol G. The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg. 2001; 93(3):573-80. DOI:10.1097/00000539-200109000-00009
52. Ahmad FI, Gerecci D, Gonzalez JD, Peck JJ, Wax MK. The role of postoperative hematoma on free flap compromise. Laryngoscope. 2015; 125(8):1811-5. DOI: 10.1002/lary.25285
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2026 Juan José López-Vélez
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
La Revista Salutem Scientia Spiritus usa la licencia Creative Commons de Atribución – No comercial – Sin derivar: Los textos de la revista son posibles de ser descargados en versión PDF siempre que sea reconocida la autoría y el texto no tenga modificaciones de ningún tipo.
